Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
Primary Purpose
Obsessive-compulsive Disorder
Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Cognitive-behavioral therapy (face-to-face)
Internet-based Cognitive-behavioral therapy
Internet-based Cognitive-behavioral therapy without therapist support
Sponsored by
About this trial
This is an interventional treatment trial for Obsessive-compulsive Disorder
Eligibility Criteria
Inclusion Criteria:
- ≥ 18 years of age,
- Internet access,
- primary diagnosis of OCD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5),
- Written consent of participation in the study.
Exclusion Criteria:
- Other psychological treatment for OCD during the treatment period,
- Adjustment of concurrent psychotropic medication within the last two months,
- bipolar disorder,
- psychosis,
- alcohol or substance dependence,
- completed CBT for OCD in the last 12 months,
- hoarding disorder or OCD with primary hoarding symptoms,
- suicidal ideation,
- subjects that lack the ability to read written Swedish or lack the cognitive ability to assimilate to the written material,
- Autism spectrum disorder,
- organic brain disorder.
Sites / Locations
- Mottagningen för Tvångssyndrom
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Active Comparator
Experimental
Experimental
Arm Label
Face-to-face CBT
Internet-based CBT
ICBT without therapist support
Arm Description
16 sessions of individual CBT delivered in 14 weeks.
Internet-based CBT (ICBT) with therapist support (14 weeks).
Internet-based CBT without therapist support (14 weeks).
Outcomes
Primary Outcome Measures
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
Secondary Outcome Measures
Clinical Global Impression - Severity (CGI-S)
Global Assessment of Functioning (GAF)
Structured Clinical Interview for DSM-5 (SCID-5) obsessive-compulsive and related disorders Structured Clinical Interview for DSM-5 (SCID-5) obsessive-compulsive and related disorders
Diagnostic status
Yale-Brown Obsessive-Compulsive Scale - self-rated (Y-BOCS)
Obsessive-Compulsive Inventory - Revised (OCI-R)
Sheehan Disability Scale (SDS)
Montgomery-Åsberg Depression Rating Scale - self-rated (MADRS-S)
Euroqol (EQ-5D)
Clinical Global Impression - Improvement (CGI-I)
Insomnia Severity Index (ISI)
Treatment credibility scale
Satisfaction with treatment scale
TiC-P
Self-rated questionnaire on healthcare utilization and productivity losses in patients with a psychiatric disorder
Safety Monitoring Uniform Report Form (SMURF)
Patient EX/RP Adherence Scale (PEAS)
Working Alliance Inventory - short revised
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02541968
Brief Title
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
Official Title
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder - a Randomized Controlled Non-inferiority Trial
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Completed
Study Start Date
September 3, 2015 (Actual)
Primary Completion Date
May 2019 (Actual)
Study Completion Date
January 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Karolinska Institutet
4. Oversight
5. Study Description
Brief Summary
Randomized controlled non-inferiority trial comparing therapist-guided Internet-based Cognitive behavioral therapy (ICBT), self-guided ICBT, and individual face-to-face (f2f) CBT for Obsessive-Compulsive Disorder (OCD) in adults.
The primary objective is to evaluate whether ICBT is a non-inferior treatment option compared to the best possible available treatment for OCD, individual face to face (f2f) CBT. A second objective is to compare the efficacy of self-guided vs. therapist-guided ICBT. As this question has cost implications for the health system, a third objective is to carry out a health economic evaluation of both forms of ICBT, in relation to the gold standard f2f CBT. A fourth objective is to explore whether ICBT is equally suited for clinic-referred cases compared to self-referred patients. Finally, a fifth objective is to investigate whether genetic markers, in combination with clinical variables, can be employed to predict treatment outcomes with CBT in general.
Research Questions:
Q1: Is therapist-guided internet-based CBT (ICBT) for OCD non-inferior to face-to-face (f2f) CBT with regard to OCD symptoms, function and quality of life?
Q2: Is entirely self-guided ICBT non-inferior to f2f CBT with regard to OCD symptoms, function and quality of life?
Q3: Is ICBT a cost-effective treatment, compared to f2f CBT?
Q4: Is there a difference in treatment outcome between self-referred and clinical referred patients?
Q5: Can clinical variables and genetic markers be useful to predict which patients will benefit from CBT?
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obsessive-compulsive Disorder
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
120 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Face-to-face CBT
Arm Type
Active Comparator
Arm Description
16 sessions of individual CBT delivered in 14 weeks.
Arm Title
Internet-based CBT
Arm Type
Experimental
Arm Description
Internet-based CBT (ICBT) with therapist support (14 weeks).
Arm Title
ICBT without therapist support
Arm Type
Experimental
Arm Description
Internet-based CBT without therapist support (14 weeks).
Intervention Type
Behavioral
Intervention Name(s)
Cognitive-behavioral therapy (face-to-face)
Other Intervention Name(s)
CBT
Intervention Type
Behavioral
Intervention Name(s)
Internet-based Cognitive-behavioral therapy
Other Intervention Name(s)
ICBT
Intervention Description
With therapist support
Intervention Type
Behavioral
Intervention Name(s)
Internet-based Cognitive-behavioral therapy without therapist support
Primary Outcome Measure Information:
Title
Yale-Brown Obsessive-Compulsive Scale (Y-BOCS)
Time Frame
Change from baseline to treatmentweek 2, 4, 6, 8, 10 , 12, 15 and 3- and 12-month follow-up.
Secondary Outcome Measure Information:
Title
Clinical Global Impression - Severity (CGI-S)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Global Assessment of Functioning (GAF)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Structured Clinical Interview for DSM-5 (SCID-5) obsessive-compulsive and related disorders Structured Clinical Interview for DSM-5 (SCID-5) obsessive-compulsive and related disorders
Description
Diagnostic status
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Yale-Brown Obsessive-Compulsive Scale - self-rated (Y-BOCS)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Obsessive-Compulsive Inventory - Revised (OCI-R)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Sheehan Disability Scale (SDS)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Montgomery-Åsberg Depression Rating Scale - self-rated (MADRS-S)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Euroqol (EQ-5D)
Time Frame
Change from baseline to treatmentweek 15, 3- and 12-month follow-up.
Title
Clinical Global Impression - Improvement (CGI-I)
Time Frame
Treatmentweek 15, 3- and 12-month follow-up.
Title
Insomnia Severity Index (ISI)
Time Frame
Treatmentweek 15, 3- and 12-month follow-up.
Title
Treatment credibility scale
Time Frame
Change from baseline to treatmentweek 2.
Title
Satisfaction with treatment scale
Time Frame
Treatmentweek 15
Title
TiC-P
Description
Self-rated questionnaire on healthcare utilization and productivity losses in patients with a psychiatric disorder
Time Frame
Treatmentweek 0, 15, 3- and 12-month follow-up.
Title
Safety Monitoring Uniform Report Form (SMURF)
Time Frame
Treatmentweek 2, 4, 6, 8, 10 , 12, 15 and 3- and 12-month follow-up.
Title
Patient EX/RP Adherence Scale (PEAS)
Time Frame
Treatmentweek 6 and 15
Title
Working Alliance Inventory - short revised
Time Frame
Change from baseline to treatment week 6 and 15
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
≥ 18 years of age,
Internet access,
primary diagnosis of OCD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5),
Written consent of participation in the study.
Exclusion Criteria:
Other psychological treatment for OCD during the treatment period,
Adjustment of concurrent psychotropic medication within the last two months,
bipolar disorder,
psychosis,
alcohol or substance dependence,
completed CBT for OCD in the last 12 months,
hoarding disorder or OCD with primary hoarding symptoms,
suicidal ideation,
subjects that lack the ability to read written Swedish or lack the cognitive ability to assimilate to the written material,
Autism spectrum disorder,
organic brain disorder.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Christian Rück
Organizational Affiliation
Karolinska Institutet
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mottagningen för Tvångssyndrom
City
Huddinge
ZIP/Postal Code
14186
Country
Sweden
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
25970252
Citation
Andersson E, Hedman E, Enander J, Radu Djurfeldt D, Ljotsson B, Cervenka S, Isung J, Svanborg C, Mataix-Cols D, Kaldo V, Andersson G, Lindefors N, Ruck C. D-Cycloserine vs Placebo as Adjunct to Cognitive Behavioral Therapy for Obsessive-Compulsive Disorder and Interaction With Antidepressants: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Jul;72(7):659-67. doi: 10.1001/jamapsychiatry.2015.0546.
Results Reference
background
PubMed Identifier
25066102
Citation
Andersson E, Steneby S, Karlsson K, Ljotsson B, Hedman E, Enander J, Kaldo V, Andersson G, Lindefors N, Ruck C. Long-term efficacy of Internet-based cognitive behavior therapy for obsessive-compulsive disorder with or without booster: a randomized controlled trial. Psychol Med. 2014 Oct;44(13):2877-87. doi: 10.1017/S0033291714000543. Epub 2014 Mar 14.
Results Reference
background
PubMed Identifier
35285923
Citation
Lundstrom L, Flygare O, Andersson E, Enander J, Bottai M, Ivanov VZ, Boberg J, Pascal D, Mataix-Cols D, Ruck C. Effect of Internet-Based vs Face-to-Face Cognitive Behavioral Therapy for Adults With Obsessive-Compulsive Disorder: A Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 1;5(3):e221967. doi: 10.1001/jamanetworkopen.2022.1967. Erratum In: JAMA Netw Open. 2022 Jul 1;5(7):e2222742. JAMA Netw Open. 2023 Jun 1;6(6):e2323948.
Results Reference
result
PubMed Identifier
30185575
Citation
Ruck C, Lundstrom L, Flygare O, Enander J, Bottai M, Mataix-Cols D, Andersson E. Study protocol for a single-blind, randomised controlled, non-inferiority trial of internet-based versus face-to-face cognitive behaviour therapy for obsessive-compulsive disorder. BMJ Open. 2018 Sep 5;8(9):e022254. doi: 10.1136/bmjopen-2018-022254.
Results Reference
derived
Learn more about this trial
Internet-based vs Face-to-face Cognitive Behavioural Therapy for Obsessive-compulsive Disorder
We'll reach out to this number within 24 hrs